Skip to content
HowShorted

Quince Therapeutics, Inc. short interest in 2020

In 2020, Quince Therapeutics, Inc.'s disclosed short interest ran from 5.25% of shares outstanding on 15 Jan 2020 to 9.82% on 31 Dec 2020, a change of +4.57 percentage points. The year's high was 9.82% on 31 Dec 2020 and its low 4.62% on 28 Feb 2020, averaging 5.75% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.35 days on 30 Oct 2020. Full history: Quince Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Quince Therapeutics, Inc. in 2020

2020 in figures

Start of year
5.25% (15 Jan 2020)
End of year
9.82% (31 Dec 2020)
Change
+4.57 pp
High
9.82% (31 Dec 2020)
Low
4.62% (28 Feb 2020)
Average
5.75%
Highest days to cover
31.35 (30 Oct 2020)
SEC filings marked
6

Every report in 2020

Quince Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20205.25%6.90
31 Jan 20205.00%10.88
14 Feb 20204.64%9.60
28 Feb 20204.62%9.49
13 Mar 20204.74%9.93
31 Mar 20205.53%12.7810-K filed, results (8-K)
15 Apr 20205.77%14.43
30 Apr 20206.99%22.59
15 May 20206.71%25.9210-Q filed, results (8-K)
29 May 20205.93%7.81
15 Jun 20205.13%7.63
30 Jun 20205.73%9.90
15 Jul 20205.27%18.44
31 Jul 20204.92%25.76
14 Aug 20204.70%25.6010-Q filed
31 Aug 20204.78%30.69
15 Sep 20205.28%14.11
30 Sep 20205.66%10.62
15 Oct 20205.35%24.25
30 Oct 20205.34%31.35
13 Nov 20206.74%15.0110-Q filed
30 Nov 20206.81%17.45
15 Dec 20207.19%5.05
31 Dec 20209.82%9.29

See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.